104,985 Transcat, Inc. $TRNS Shares Sold by Conestoga Capital Advisors LLC

Key Points

• Conestoga Capital Advisors cut its Transcat stake by 23.4%, selling 104,985 shares in the third quarter; it still held 344,572 shares, or 3.67% of the company.
• Transcat reported quarterly earnings of $0.64 per share and revenue of $97.09 million, beating analyst estimates of $0.45 and $92.46 million, respectively.
• Analyst views were mixed: Oppenheimer upgraded Transcat to “outperform” with a $115 target, while the overall consensus remained “Hold” with a $108.33 price target.

Conestoga Capital Advisors LLC lowered its position in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 23.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 344,572 shares of the scientific and technical instruments company's stock after selling 104,985 shares during the quarter. Conestoga Capital Advisors LLC owned 3.67% of Transcat worth $30,467,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. BlackRock Inc. acquired a new position in Transcat in the 2nd quarter worth approximately $67,445,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Transcat during the 2nd quarter valued at $37,106,000. Wellington Management Group LLP acquired a new stake in Transcat during the 2nd quarter valued at $29,409,000. Dimensional Fund Advisors LP raised its stake in Transcat by 3.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company's stock valued at $19,244,000 after purchasing an additional 9,266 shares during the period. Finally, Bamco Inc. NY purchased a new stake in shares of Transcat in the second quarter valued at $17,649,000. Hedge funds and other institutional investors own 98.34% of the company's stock.

Transcat Price Performance

NASDAQ:TRNS opened at $108.13 on Thursday. The company has a 50-day moving average of $86.49 and a 200-day moving average of $82.05. The company has a market capitalization of $1.02 billion, a price-to-earnings ratio of 225.28 and a beta of 0.61. Transcat, Inc. has a 52 week low of $50.23 and a 52 week high of $110.47. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.49.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.19. Transcat had a net margin of 1.26% and a return on equity of 6.18%. The business had revenue of $97.09 million for the quarter, compared to analyst estimates of $92.46 million. As a group, equities research analysts anticipate that Transcat, Inc. will post 1.79 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Oppenheimer raised Transcat from a "market perform" rating to an "outperform" rating and set a $115.00 target price for the company in a research report on Wednesday. CJS Securities assumed coverage on Transcat in a research report on Tuesday, October 27th. They set an "outperform" rating and a $115.00 price target on the stock. Northland Securities upgraded shares of Transcat from a "market perform" rating to an "outperform" rating and set a $95.00 price objective on the stock in a research note on Wednesday, October 21st. Finally, Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Transcat in a research note on Tuesday, August 25th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Transcat presently has a consensus rating of "Hold" and a consensus price target of $108.33.

Insider Buying and Selling at Transcat

In related news, Director Christopher P. Gillette sold 504 shares of the firm's stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $94.23, for a total transaction of $47,491.92. Following the completion of the transaction, the director owned 200 shares in the company, valued at $18,846. This trade represents a 71.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.80% of the company's stock.

Key Transcat News

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Quarterly results beat expectations. Transcat reported adjusted earnings of $0.64 per share, ahead of analyst estimates of roughly $0.42–$0.45 and up from $0.44 a year earlier. Revenue of $97.09 million also exceeded the $92.46 million consensus. Article: Transcat Q2 earnings and revenues top estimates
• Positive Sentiment: Service growth and margins strengthened. The company raised its fiscal 2027 organic service-growth outlook to the low double digits and is targeting at least 100 basis points of service gross-margin expansion in the second half. Reports also pointed to service momentum and acquisitions as contributors to the quarter’s outperformance. Article: Transcat raises service growth outlook
• Positive Sentiment: Oppenheimer upgraded the stock. The firm raised its rating from “market perform” to “outperform” and set a $115 price target, adding to the favorable reaction to the results and outlook. Article: Oppenheimer stock recommendations

Transcat Profile

Transcat, Inc NASDAQ: TRNS provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.